Terms: = Lung cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Treatment
62 results:
1. Real-world outcomes associated with afatinib use in patients with solid tumors harboring nrg1 gene fusions.
Liu SV; Frohn C; Minasi L; Fernamberg K; Klink AJ; Gajra A; Savill KMZ; Jonna S
Lung Cancer; 2024 Feb; 188():107469. PubMed ID: 38219288
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive biomarkers in non-small cell lung carcinoma.
Odintsov I; Sholl LM
Pathology; 2024 Mar; 56(2):192-204. PubMed ID: 38199926
[TBL] [Abstract] [Full Text] [Related]
3. Adipocyte Precursor-Derived nrg1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.
Hosni S; Kilian V; Klümper N; Gabbia D; Sieckmann K; Corvino D; Winkler A; Saponaro M; Wörsdörfer K; Schmidt D; Hahn O; Zanotto I; Bertlich M; Toma M; Bald T; Eckstein M; Hölzel M; Geyer M; Ritter M; Wachten D; De Martin S; Alajati A
Cancer Res; 2024 Mar; 84(5):725-740. PubMed ID: 38175774
[TBL] [Abstract] [Full Text] [Related]
4. Fluorescent in situ hybridization has limitations in screening nrg1 gene rearrangements.
Zhang X; Li L; Gao F; Liu B; Li J; Ren S; Peng S; Qiu W; Pu X; Ye Q
Diagn Pathol; 2024 Jan; 19(1):1. PubMed ID: 38173003
[TBL] [Abstract] [Full Text] [Related]
5. HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of cancer.
Majumder A
Cells; 2023 Oct; 12(21):. PubMed ID: 37947595
[TBL] [Abstract] [Full Text] [Related]
6. Durable response to afatinib in advanced lung adenocarcinoma harboring a novel NPTN-nrg1 fusion: a case report.
Nie X; Zhang P; Bie Z; Song C; Zhang M; Ma D; Cui D; Cheng G; Li H; Lei Y; Su X; Wu W; Li L
World J Surg Oncol; 2023 Aug; 21(1):246. PubMed ID: 37587479
[TBL] [Abstract] [Full Text] [Related]
7. Encouraging adherence in adolescents with asthma using financial incentives: An RCT.
Keyser HH; Brinton JT; Bothwell S; Camacho M; Kempe A; Szefler SJ
Pediatr Pulmonol; 2023 Oct; 58(10):2823-2831. PubMed ID: 37449768
[TBL] [Abstract] [Full Text] [Related]
8. Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer.
Hisakane K; Seike M; Sugano T; Matsuda K; Kashiwada T; Nakamichi S; Matsumoto M; Miyanaga A; Noro R; Kubota K; Gemma A
Gene; 2023 Mar; 857():147177. PubMed ID: 36623674
[TBL] [Abstract] [Full Text] [Related]
9. A case of multiple primary lung adenocarcinoma with a CD74-nrg1 fusion protein and HER2 mutation benefit from combined target therapy.
Chen K; Li W; Xi X; Zhong J
Thorac Cancer; 2022 Nov; 13(21):3063-3067. PubMed ID: 36096509
[TBL] [Abstract] [Full Text] [Related]
10. Real-World Clinical Outcomes after Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Advanced Non-Small Cell lung cancer.
Olsen S; Liao J; Hayashi H
Curr Oncol; 2022 Jul; 29(7):4811-4826. PubMed ID: 35877242
[TBL] [Abstract] [Full Text] [Related]
11. Plain language summary of nrg1 fusions in cancer: current knowledge and treatment with afatinib and other drugs.
Liu SV
Future Oncol; 2022 Aug; 18(26):2865-2870. PubMed ID: 35876504
[TBL] [Abstract] [Full Text] [Related]
12. Plain language summary of publication: new information for the potential role of afatinib in treating people with
Cadranel J
Future Oncol; 2022 Jun; 18(18):2193-2200. PubMed ID: 35400204
[TBL] [Abstract] [Full Text] [Related]
13. Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by nrg1 Gene Rearrangements.
Schram AM; Odintsov I; Espinosa-Cotton M; Khodos I; Sisso WJ; Mattar MS; Lui AJW; Vojnic M; Shameem SH; Chauhan T; Torrisi J; Ford J; O'Connor MN; Geuijen CAW; Schackmann RCJ; Lammerts van Bueren JJ; Wasserman E; de Stanchina E; O'Reilly EM; Ladanyi M; Drilon A; Somwar R
Cancer Discov; 2022 May; 12(5):1233-1247. PubMed ID: 35135829
[TBL] [Abstract] [Full Text] [Related]
14. Prognosis-related autophagy genes in female lung adenocarcinoma.
Liu Z; Zhang K; Zhao Z; Qin Z; Tang H
Medicine (Baltimore); 2022 Jan; 101(1):e28500. PubMed ID: 35029906
[TBL] [Abstract] [Full Text] [Related]
15. RENORT: a project to analyze patterns of care in radiation oncology in Spain.
López-Torrecilla J; Palacios Eito A; Gómez-Caamaño A; Salinas Ramos J; Samper Ots P; Rodríguez Pérez A
Clin Transl Oncol; 2022 Jul; 24(7):1322-1332. PubMed ID: 35028930
[TBL] [Abstract] [Full Text] [Related]
16. nrg1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows.
Trombetta D; Sparaneo A; Fabrizio FP; Di Micco CM; Rossi A; Muscarella LA
Expert Opin Ther Targets; 2021 Oct; 25(10):865-875. PubMed ID: 34706602
[TBL] [Abstract] [Full Text] [Related]
17. The potential targeted drugs for fusion genes including nrg1 in pancreatic cancer.
Umemoto K; Sunakawa Y
Crit Rev Oncol Hematol; 2021 Oct; 166():103465. PubMed ID: 34454058
[TBL] [Abstract] [Full Text] [Related]
18. The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.
Melosky B; Wheatley-Price P; Juergens RA; Sacher A; Leighl NB; Tsao MS; Cheema P; Snow S; Liu G; Card PB; Chu Q
Lung Cancer; 2021 Oct; 160():136-151. PubMed ID: 34353680
[TBL] [Abstract] [Full Text] [Related]
19. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
Wang L; Guo W; Guan H; Yan N; Cai X; Zhu L
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22871. PubMed ID: 34338398
[TBL] [Abstract] [Full Text] [Related]
20. A Phase I, First-in-Human Study of GSK2849330, an Anti-HER3 Monoclonal Antibody, in HER3-Expressing Solid Tumors.
Gan HK; Millward M; Jalving M; Garrido-Laguna I; Lickliter JD; Schellens JHM; Lolkema MP; Van Herpen CLM; Hug B; Tang L; O'Connor-Semmes R; Gagnon R; Ellis C; Ganji G; Matheny C; Drilon A
Oncologist; 2021 Oct; 26(10):e1844-e1853. PubMed ID: 34132450
[TBL] [Abstract] [Full Text] [Related]
[Next]
